Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 30B pseudogene 3 (ANKRD30BP3) is a human pseudogene located on chromosome 10 and annotated in gene databases such as NCBI Gene (ID: 338579), Ensembl (ENSG00000230501), and HGNC (ID: 27873)[9][5][6]. As a pseudogene, it does not encode a functional protein and no biological function, disease association, or therapeutic drug targeting is reported for this locus[2][6][9]. Alternate names include NCRNA00164 and "putative ankyrin repeat domain-containing protein 30B-like," but there is no evidence it serves as a receptor, enzyme, transporter, or other traditional drug target[7][8]. The annotation is correct, there is no misspelling or confusion, but it is not functionally relevant to therapeutic development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 30B pseudogene 3 (ANKRD30BP3).